IP Library Granted Patent US 12,426,615
Granted Patent B2
US 12,426,615 · App. 17/432,065 · Granted Sep 30, 2025

Compositions comprising choline and omega-3 fatty acid to nutritionally enhance food products

Inventors: Jonathan Wolfson (Portola Valley, CA); Mark Brooks (Corte Madera, CA); Katharine Noakes (San Francisco, CA)
Assignee: Ingenuity Foods, Inc.
A23L33/12A23C9/1307A23C9/1315A23C9/1322A23C9/1522A23C9/1526A23C9/1528A23C9/156A23C19/0917A23C19/0921A23L9/12A23L19/09A23L33/135A23L33/19A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,426,615
App. No.
17/432,065
Granted
Sep 30, 2025
Kind
B2
Abstract

Provided herein is a composition that includes choline or choline salt and omega-3 fatty acid for nutritionally enhancing a food product, as well as the resultant food products. The food product when nutritionally enhanced with the composition has an acceptable taste or acceptable odor or the food product has a peroxide value of less than 50 mEq. Methods of preparing the composition and food products are also are provided. As seen in the accompanying figure the discoveries outlined herein have resulted in an unprecedented level of organoleptic stability over time, with no significant change to key sensory parameters typically seen in products that contain high levels of choline and omega-3 fatty acids.

Claims (18)

1. A nutritionally enhanced food composition that is ready for consumption and is fortified with a form of choline that provides between 0.75 mg/g and 5 mg/g free choline, between 0.25 mg/g and 5 mg/g omega-3 fatty acid, and an antioxidant,

wherein the nutritionally enhanced food composition is a fruit or vegetable preparation comprising no added protein,

the form of choline comprising a choline salt or phosphotidyl choline,

the omega-3 fatty acid comprising DHA in combination with ALA or EPA, and

the antioxidant selected from the group consisting of tocopherols, rosemary extract, and vitamin C, and

wherein the nutritionally enhanced food composition can be stored without refrigeration or freezing for at least 4 weeks.

2. The nutritionally enhanced food composition of claim 1 , wherein the peroxide value of the food composition is less than 50 mEq, less than 40 mEq, less than 35 mEq, less than 30 mEq, less than 25 mEq, less than 20 mEq, less than 15 mEq, less than 10 mEq, or less than 5 mEq.

3. The nutritionally enhanced food composition of claim 1 , wherein the form of choline comprises choline salt, and the omega-3 fatty acid comprises DHA and ALA.

4. The nutritionally enhanced food composition of claim 1 , wherein the nutritionally enhanced food composition comprises a probiotic or an active culture, optionally wherein the probiotic or active culture comprises Lactobacillus, Bifidobacterium, Saccharomyces, Enterococcus, Streptococcus, Pediococcus, Leuconostoc , or Bacillus.

5. The nutritionally enhanced food composition of claim 1 , wherein the form of choline comprises a choline salt at a concentration of up to 4 mg/g, up to 3.5 mg/g, up to 3 mg/g, up to 2.5 mg/g, up to 2 mg/g, up to 1.75 mg/g, up to 1.5 mg/g, up to 1.25 mg/g, and up to 1 mg/g.

6. The nutritionally enhanced food composition of claim 1 , wherein the amount of the omega-3 fatty acid is between 0.25 mg/g and 4 mg/g, between 0.25 mg/g and 3.5 mg/g, between 0.25 mg/g and 3 mg/g, between 0.25 mg/g and 2.5 mg/g, between 0.25 mg/g and 2 mg/g, between 0.25 mg/g and 1.75 mg/g, between 0.25 mg/g and 1.5 mg/g, between 0.25 mg/g and 1.25 mg/g, and between 0.25 mg/g and 1 mg/g.

7. The nutritionally enhanced food composition of claim 1 , wherein the choline salt is selected from the group consisting of choline acetate, choline bicarbonate, choline chloride, choline citrate, choline bitartrate, and choline lactate.

8. The nutritionally enhanced food composition of claim 1 , wherein the omega-3 fatty acid is encapsulated.

9. The nutritionally enhanced food composition of claim 1 , wherein the nutritionally enhanced food composition comprises iron.

10. The nutritionally enhanced food composition of claim 9 , wherein the iron is encapsulated.

11. The nutritionally enhanced food composition of claim 1 , wherein the nutritionally enhanced food composition comprises a probiotic or an active culture, wherein the probiotic or active culture comprises Lactobacillus, Bifidobacterium, Saccharomyces, Enterococcus, Streptococcus, Pediococcus, Leuconostoc , or Bacillus.

12. The nutritionally enhanced food composition of claim 1 , wherein the choline comprises a choline salt at a concentration of between 0.75 mg/g and 2 mg/g.

13. The nutritionally enhanced food composition of claim 1 , wherein the omega-3 fatty acid comprises omega-3 fatty acid at a concentration of between 0.25 mg/g and 1 mg/g.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2026
From: INGENUITY FOODS, INC.
To: INGENUITY FOODS, LLC
Reel/Frame 074935/0810 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2026
From: INGENUITY FOODS, INC.
To: INGENUITY FOODS, LLC
Reel/Frame 074851/0075 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2025
From: WOLFSON, JONATHAN; BROOKS, MARK; NOAKES, KATHARINE
To: INGENUITY FOODS, INC.
Reel/Frame 069858/0430 →
PATENT SECURITY AGREEMENT Recorded Feb 27, 2023
From: INGENUITY FOODS, INC.
To: CRIMSONOX CAPITAL PTE LTD
Reel/Frame 062879/0091 →
Continuity (4)
Provisional Application 62928285 · Oct 30, 2019
Provisional Application 62808716 · Feb 21, 2019
Provisional Application 62808717 · Feb 21, 2019
Related Publication 20220167652A1 · Jun 2, 2022
References Cited (48)
US 4895725A · Kantor et al. · 1990 [cited by applicant]
US 6153653A · Shashoua · 2000 [cited by applicant]
US 9986747B2 · Taillan et al. · 2018 [cited by applicant]
US 20070048405A1 · DeWille et al. · 2007 [cited by applicant]
US 20090162518A1 · Clinger et al. · 2009 [cited by applicant]
US 20110028434A1 · Destaillats et al. · 2011 [cited by applicant]
US 20120015070A1 · Vanderkooi et al. · 2012 [cited by applicant]
US 20130115258A1 · Singh et al. · 2013 [cited by applicant]
US 20140271998A1 · Hecht · 2014 [cited by examiner]
US 20150174080A1 · Schiffrin · 2015 [cited by examiner]
US 20160128367A1 · Huntsman · 2016 [cited by applicant]
US 20160317600A1 · Johns · 2016 [cited by examiner]
CN 104187740A · 2014 [cited by examiner]
EP 0641562A1 · 1995 [cited by applicant]
JP H02103289A · 1990 [cited by applicant]
JP H07149664A · 1995 [cited by applicant]
JP 2000060424A · 2000 [cited by applicant]
JP 2011507518A · 2011 [cited by applicant]
JP 2012531914A · 2012 [cited by applicant]
JP 2015530981A · 2015 [cited by applicant]
WO WO2008024906A2 · 2008 [cited by applicant]
WO WO2009085388A2 · 2009 [cited by applicant]
WO WO2010040789A1 · 2010 [cited by applicant]
WO WO2011002802A2 · 2011 [cited by applicant]
WO WO2014020004A1 · 2014 [cited by applicant]
WO WO2015069678A1 · 2015 [cited by applicant]
WO WO2016014514A1 · 2016 [cited by applicant]
WO WO2017182299A1 · 2017 [cited by applicant]
WO WO2018183251A1 · 2018 [cited by applicant]
WO WO2018195601A1 · 2018 [cited by applicant]
“Best Sources of Choline”. Available online from https://www.gbhealthwatch.com, pp. 1-5, available online as of Mar. 11, 2016 (Year: 2016). [cited by examiner]
“Best Sources of Omega-3”. Available online from https://www.gbhealthwatch.com, pp. 1-5, available online as of Mar. 13, 2016. (Year: 2016). [cited by examiner]
Machine translation of CN104187740 to Huang et al. Published Oct. 12, 2014, pp. 1-4. (Year: 2014). [cited by examiner]
Costanzo, M. et al., “Krill Oil, Vitamin D and Lactobacillus Reuteri Cooperate to Reduce Gut Inflammation”, Beneficial Microbes, Nov. 23, 2018, vol. 9, No. 3, pp. 389-399. [cited by applicant]
Dias D R et al., “Encapsulation As a Tool for Bioprocessing of Functional Foods,” Current Opinion in Food Science, 2017, vol. 13, pp. 31-37. [cited by applicant]
Extended European Search Report dated Nov. 18, 2022 in EP Application No. EP20759524. [cited by applicant]
International Preliminary Report on Patentability dated Sep. 2, 2021, in Application No. PCT/US2020/019354. [cited by applicant]
International Search Report and Written Opinion dated May 4, 2020, in Application No. PCT/US2020/019354. [cited by applicant]
Lawless H., “The Sense of Smell in Food Quality and Sensory Evaluation,” 1991, 28 pages. [cited by applicant]
Mcginley C M., et al., ““Odor Basics”, Understanding and Using Odor Testing,” 2000, 16 Pages. [cited by applicant]
Rajarethnem H T, et al., “Combined Supplementation of Choline and Docosahexaenoic Acid during Pregnancy Enhances Neurodevelopment of Fetal Hippocampus,” Neurology Research International, 2017, 8748706, 10 Pages. [cited by applicant]
SG Search Report and Written Opinion dated Jan. 9, 2023 in Application No. SG11202109062T. [cited by applicant]
Siefarth C., et al., “Comparative Evaluation of Diagnostic Tools for Oxidative Deterioration of Polyunsaturated Fatty Acid-Enriched Infant Formulas during Storage,” Foods, 2014, vol. 3, pp. 30-65. [cited by applicant]
Wurtman R J et al., “A Nutrient Combination that Can Affect Synapse Formation,” Nutrients, 2014, vol. 6, pp. 1701-1710. [cited by applicant]
CN Office Action dated Dec. 26, 2023 in CN Application No. 202080030177.X, with English Translation. [cited by applicant]
JP Office Action dated Feb. 5, 2024 in Application No. JP2021-549451 with English Translation. [cited by applicant]
CN Office Action dated Oct. 31, 2024 in CN Application No. 202080030177.X, with English Translation. [cited by applicant]
JP Office Action dated Nov. 25, 2024 in JP Application No. 2021-549451, with English Translation. [cited by applicant]